Nyrada’s PCSK9 Inhibitor Evaluated In Novel Model Of Atherosclerosis Jul 20, 2022 | ASX News, Nyrada Inc (ASX:NYR)
MoneyTalks: Canary Capital’s Paul Hart is bullish about the biotech sector – here’s why Nov 5, 2021 | ASX News, General News